MLTX CLASS NOTICE: Suffer Losses on MoonLake Immunotherapeutics? Investors are Reminded to Contact BFA Law before December 15 Court Deadline
NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ:MLTX) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in MoonLake, you are encouraged […]